Pseudohypoparathyroidism: one gene, several syndromes

Area of Science:

• Genetics and Epigenetics
• Endocrinology
• Molecular Biology

Background:

• Pseudohypoparathyroidism (PHP) and pseudopseudohypoparathyroidism (PPHP) are genetic disorders linked to the GNAS locus on chromosome 20q13.3.
• The GNAS locus encodes the alpha-subunit of the stimulatory G protein (Gsα), crucial for various cellular signaling pathways.
• Parent-specific methylation patterns at the GNAS locus are critical for its normal function.

Purpose of the Study:

• To elucidate the genetic and epigenetic mechanisms underlying PHP and PPHP.
• To understand the relationship between GNAS mutations/epigenetic changes and resulting Gsα protein deficiency.
• To differentiate the clinical manifestations of PHP type Ia (PHP1A), PHP type Ib (PHP1B), and PPHP.

Main Methods:

• Analysis of GNAS locus mutations and epigenetic alterations (methylation patterns).
• Investigation of Gsα protein expression in affected tissues.
• Correlation of molecular findings with clinical phenotypes, including Albright's hereditary osteodystrophy (AHO).

Main Results:

• Heterozygous maternal GNAS inactivating mutations cause PHP1A, leading to PTH-resistant hypocalcemia and hyperphosphatemia due to reduced Gsα.
• Paternal GNAS mutations cause PPHP, often without biochemical abnormalities but may present with some AHO features.
• Maternal deletions or loss-of-methylation (LOM) at GNAS/STX16 cause autosomal dominant PHP1B, resulting in hormonal resistance.
• Sporadic PHP1B involves epigenetic changes at GNAS, with rare cases linked to paternal uniparental disomy of chromosome 20q.

Conclusions:

• GNAS locus defects, including mutations and epigenetic dysregulation, are the primary cause of PHP and PPHP.
• The parent of origin and specific molecular defect dictate the biochemical and clinical phenotype.
• Understanding these GNAS-related disorders is essential for accurate diagnosis and management of hormonal resistance and developmental abnormalities.